Progress in applying genomics in drug development

Toxicology Letters

Volumn 149, Issue 1-3, 2004, Pages 371-375

  Lord, Peter G ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Mechanism based risk assessment; Predictive toxicology; Review; Toxicogenomics

Indexed keywords

CARCINOGEN; POTASSIUM BROMATE; XENOBIOTIC AGENT;

CARCINOGENESIS; CONFERENCE PAPER; DATA BASE; DRUG SYNTHESIS; GENE EXPRESSION; GENOMICS; HUMAN; MATHEMATICAL COMPUTING; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMALS; DRUG DESIGN; FORECASTING; GENE EXPRESSION; HUMANS; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; TOXICOGENETICS; TOXICOLOGY;

EID: 1842766394     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.12.045     Document Type: Conference Paper

References (21)

1. Burczynski M.E., McMillian M., Ciervo J., Li L., Parker J.B., Dunn R.T., Hicken S., Farr S., Johnson M.D. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci. 58:2000;399-415.
2. Crosby L.M., Hyder K.S., DeAngelo A.B., Kepler T.B., Gaskill B., Benavides G.R., Yoon L., Morgan K.T. Morphologic analysis correlates with gene expression changes in cultured F344 rat mesothelial cells. Toxicol. Appl. Pharmacol. 169:2000;205-221.
3. Farr S., Dunn R.T. Gene expression applied to toxicology. Toxicol. Sci. 50:1999;1-9.
4. Fielden M.R., Zacharewski T.R. Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. Toxicol. Sci. 60:2001;6-10.
5. Garcia-Allan C., Loughlin J., Orton T.C., Lord P.G. Expression of growth factor receptors and their mRNAs in livers of mice and rats following administration of non-genotoxic carcinogens. Arch. Toxicol. 71:1997;409-415.
6. Hamadeh H.K., Bushel P.R., Jayadev S., Martin K., DiSorbo O., Sieber S., Bennett L., Tennant R., Stoll R., Barrett J.C., Blanchard K., Paules R.S., Afshari C.A. Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 67:2002;219-231.
7. Harries H.M., Fletcher S.T., Duggan C.M., Baker V.A. The use of genomics technology to investigate gene expression changes in cultured human liver cells. Toxicol. In Vitro. 15:2001;399-405.
8. Kozian D.H., Kirschbaum B.J. Comparative gene-expression analysis. Trends Biotechnol. 17:1999;73-78.
9. Lesko L.J., Salerno R.A., Spear B.B., Anderson D.C., Anderson T., Brazell C., Collins J., Dorner A., Essayan D., Gomez-Mancilla B., Hackett J., Huang S.M., Ide S., Killinger J., Leighton J., Mansfield E., Meyer R., Ryan S.G., Schmith V., Shaw P., Sistare F., Watson M., Worobec A. Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop [Journal Article]. J. Clin. Pharmacol. 43:2003;342-358.
10. Lord P.G., Barne K.A., Kramer K., Bacon E.J., Mooney J., O'Brien S., Bugelski P.J. cDNA microarrays in investigative toxicology: a study of differential gene expression in compound induced cardiac hypertrophy. Comments Toxicol. 7:2001;381-392.
11. Macgregor J.T., Farr S., Tucker J.D., Heddle J.A., Tice R.R., Turteltaub K.W. New molecular endpoints and methods for routine toxicity testing. Fund. Appl. Toxicol. 26:1995;156-173.
12. Nuwaysir E.F., Bittner M., Trent J., Barrett J.C., Afshari C.A. Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinogenesis. 24:1999;153-159.
13. Orton T.C., Doughty S.E., Kalinowski A.E., Lord P.G., Wadsworth P.F. Expression of growth factors and growth factor receptors in the liver of C57BL/10J mice following administration of phenobarbitone. Carcinogenesis. 15:1996;973-981.
14. Petricoin E.F., Hackett J.L., Lesko L.J., Puri R.K., Gutman S.I., Chumakov K., Woodcock J., Feigal D.W., Zoon K.C., Sistare F.D. Medical applications of microarray technologies: a regulatory science perspective. Nature Genet. Suppl. 32:2002;474-479.
15. Rockett J.C., Esdaile D.J., Gibson G.G. Differential gene expression in drug metabolism and toxicology: practicalities. Xenobiotica. 29:1999;655-691.
16. Rumsby P.C., Davies M.J., Price R.J., Lake B.G. Effect of some peroxisome proliferators on transforming growth factor-b1 gene expression and insulin-like growth factor II/mannose-6-phosphate receptor gene expression in rat liver. Carcinogenesis. 15:1994;419-421.
17. Smith L.L. Key challenges for toxicologists in the 21st century. Trends Pharmacol. Sci. 22:2001;281-285.
18. Thomas R.S., Rank D.R., Penn S.G., Zastrow G.M., Hayes K.R., Pande K., Glover E., Silander T., Craven M.W., Reddy J.K., Jovanovich S.B., Bradfield C.A. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. 60:2001;1189-1194.
19. Ulrich R., Friend S.H. Toxicogenomics and drug discovery: will new technologies help us produce better drugs? Nature Rev. Drug Discovery. 1:2002;84-88.
20. Varmus H.E. The molecular genetics of cellular oncogenes. Annu. Rev. Genet. 18:1985;553-612.
21. Waring J.F., Ciurlionis R., Jolly R.A., Heindel M., Ulrich R.G. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. 120:2001;359-368.